After different types of acute central nervous system insults, including stroke, subarachnoid
haemorrhage and traumatic brain and spinal cord injuries, secondary damage plays a …

Abstract Purpose of Review While clinicians have been using antidepressants for off-label
indications in the treatment of chronic pain in recent years, newer studies have proven …

Abstract Purpose of Review Researchers suggests that patients with COVID-19 develop
neuropathic pain within weeks or months following infection and that patients with …

Knowledge about the mechanisms of transmission and the processing of nociceptive
information, both in healthy and pathological states, has greatly expanded in recent years …

To unravel the complexity of the neuropathic pain experience, researchers have tried to
identify reliable pain signatures (biomarkers) using electroencephalography (EEG) and skin …

This umbrella review aimed to determine the various drugs used to treat trigeminal neuralgia
(TN) and to evaluate their efficacies as well as side effects by surveying previously …

Despite the prevalence of opioid misuse, opioids remain the frontline treatment regimen for
severe pain. However, opioid safety is hampered by side-effects such as analgesic …

Neuropathic pain conditions including neuropathic orofacial pain (NOP) are difficult to treat.
Contemporary therapeutic agents for neuropathic pain are often ineffective in relieving pain …

Neuropathic pain is generally defined as a non-physiological pain experience caused by
damage to the nervous system. It can occur spontaneously, as a reaction to a given stimulus …

This study aimed to disclose differentially expressed genes (DEGs) in dorsal root ganglia
(DRGs) of neuropathic pain (NP) from spared nerve injury (SNI) model, thereby identifying …